Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
J Cardiovasc Electrophysiol ; 34(2): 348-355, 2023 02.
Article in English | MEDLINE | ID: mdl-36448428

ABSTRACT

INTRODUCTION: Early and safe ambulation can facilitate same-day discharge (SDD) following catheter ablation, which can reduce resource utilization and healthcare costs and improve patient satisfaction. This study evaluated procedure success and safety of the VASCADE MVP venous vascular closure system in patients with atrial fibrillation (AF). METHODS: The AMBULATE SDD Registry is a two-stage series of postmarket studies in patients with paroxysmal or persistent AF undergoing catheter ablation followed by femoral venous access-site closure with VASCADE MVP. Efficacy endpoints included SDD success, defined as the proportion of patients discharged the same day who did not require next-day hospital intervention for procedure/access site-related complications, and access site sustained success within 15 days of the procedure. RESULTS: Overall, 354 patients were included in the pooled study population, 151 (42.7%) treated for paroxysmal AF and 203 (57.3%) for persistent AF. SDD was achieved in 323 patients (91.2%) and, of these, 320 (99.1%) did not require subsequent hospital intervention based on all study performance outcomes. Nearly all patients (350 of 354; 98.9%) achieved total study success, with no subsequent hospital intervention required. No major access-site complications were recorded. Patients who had SDD were more likely to report procedure satisfaction than patients who stayed overnight. CONCLUSION: In this study, 99.7% of patients achieving SDD required no additional hospital intervention for access site-related complications during follow-up. SDD appears feasible and safe for eligible patients after catheter ablation for paroxysmal or persistent AF in which the VASCADE MVP is used for venous access-site closure.


Subject(s)
Atrial Fibrillation , Catheter Ablation , Humans , Patient Discharge , Atrial Fibrillation/diagnosis , Atrial Fibrillation/surgery , Atrial Fibrillation/etiology , Patient Satisfaction , Catheter Ablation/adverse effects , Catheter Ablation/methods , Registries , Treatment Outcome
2.
Int J Cardiol ; 147(3): 438-43, 2011 Mar 17.
Article in English | MEDLINE | ID: mdl-20971517

ABSTRACT

BACKGROUND: There is conflicting data regarding the mortality benefit of statins in patients with heart failure. The objectives of our study were to determine whether statin therapy is associated with decreased all-cause mortality and to assess the effect of incremental duration of therapy. METHODS: We studied 10,510 consecutive patients from the Veterans Affairs health system with a diagnosis of heart failure from January 2002 through December 2006. Mean follow-up was 2.66 years. Statin use and duration of therapy were identified. Veterans were classified into four groups based on duration of statin use during the study period (none, 1-25%, 26-75% and >75% use of statins). Logistic regression was performed to identify the association between incident statin use and all-cause mortality following a diagnosis of heart failure. The Kaplan-Meier method was employed to assess for differences in survival time between the four statin use classifications. RESULTS: Statin use was significantly associated with decreased all-cause mortality following a diagnosis of heart failure after controlling for age, gender, concurrent medications and comorbid diagnoses [χ(3)(2) (N = 10,510) = 1077.82, p < 0.001]. The benefit was seen within a relatively short duration (within 1 year) after starting statins, and in patients with <25% use of statins, there was no mortality benefit. CONCLUSION: Veterans who were not exposed to statin therapy at any time during the study period were 1.56 times more likely to suffer all-cause mortality.


Subject(s)
Heart Failure/drug therapy , Heart Failure/mortality , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Veterans , Aged , Aged, 80 and over , Cohort Studies , Female , Follow-Up Studies , Humans , Longitudinal Studies , Male , Middle Aged , Retrospective Studies
3.
South Med J ; 103(11): 1186-8, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20890255

ABSTRACT

Pseudoaneurysm of the thoracic aorta is an extremely rare and potentially fatal condition that can mimic acute coronary syndrome, aortic dissection, or pulmonary embolism. Chest trauma and aortic surgery are the usual predisposing factors. Rarely, noncardiovascular thoracic surgeries can result in aortic pseudoaneurysm secondary to unrecognized perioperative injury. Clinical presentation is very variable, and a high index of suspicion is necessary for diagnosis. Computed tomography or magnetic resonance angiography is the preferred diagnostic test. In this paper, we report the case of a 58-year-old woman who presented with atypical chest pain due to a thoracic aortic pseudoaneurysm, most likely a result of previous nonvascular surgery.


Subject(s)
Aneurysm, False/etiology , Aorta, Thoracic , Chest Pain/etiology , Postoperative Complications/diagnosis , Aneurysm, False/diagnosis , Female , Humans , Lung Neoplasms/complications , Lung Neoplasms/surgery , Magnetic Resonance Angiography , Middle Aged , Pneumonectomy
4.
Tex Heart Inst J ; 36(4): 355-7, 2009.
Article in English | MEDLINE | ID: mdl-19693316

ABSTRACT

Eosinophilic myocarditis is characterized by progressive myocardial damage that results in heart failure and death. Herein, we present the case of a 54-year-old man who presented with symptoms of acute myocardial infarction. Normal coronary angiographic results and the presence of elevated levels of peripheral-blood eosinophilia prompted an endomyocardial biopsy that revealed acute eosinophilic myocarditis. The early initiation of steroid therapy resulted in the patient's substantial clinical improvement and survival. Early diagnosis of eosinophilic myocarditis and its treatment with steroid agents in some patients can lead to a favorable outcome. We discuss the challenge of diagnosing and identifying the characteristics of this variant of necrotizing eosinophilic myocarditis before the condition proves fatal.


Subject(s)
Eosinophilia/diagnosis , Myocardial Infarction/diagnosis , Myocarditis/diagnosis , Myocardium/pathology , Biopsy , Coronary Angiography , Diagnosis, Differential , Early Diagnosis , Echocardiography , Eosinophilia/drug therapy , Humans , Male , Middle Aged , Myocarditis/drug therapy , Necrosis , Steroids/therapeutic use , Treatment Outcome
5.
J Am Soc Echocardiogr ; 22(10): 1165-72, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19647401

ABSTRACT

BACKGROUND: The aim of this study was to determine the ability to identify thrombus within the left atrial appendage (LAA) in the setting of atrial fibrillation (AF) using transthoracic echocardiography (TTE). In AF, the structure and function of the LAA has historically been evaluated using transesophageal echocardiography (TEE). The role of TTE remains undefined. METHODS: The Comprehensive Left Atrial Appendage Optimization of Thrombus (CLOTS) multicenter study enrolled 118 patients (85 men; mean age, 67 +/- 13 years) with AF of >2 days in duration undergoing clinically indicated TEE. On TEE, the LAA was evaluated for mild spontaneous echo contrast (SEC), severe SEC, sludge, or thrombus. Doppler Tissue imaging (DTI) peak S-wave and E-wave velocities of the LAA walls (anterior, posterior, and apical) were acquired on TTE. Transthoracic echocardiographic harmonic imaging (with and without intravenous contrast) was examined to determine its ability to identify LAA SEC, sludge, or thrombus. RESULTS: Among the 118 patients, TEE identified 6 (5%) with LAA sludge and 2 (2%) with LAA thrombi. Both LAA thrombi were identified on TTE using harmonic imaging with contrast. Anterior, posterior, and apical LAA wall DTI velocities on TTE varied significantly among the 3 groups examined (no SEC, mild SEC, severe SEC, sludge or thrombus). An apical E velocity < or = 9.7 cm/s on TTE best identified the group of patients with severe SEC, sludge, or thrombus. An anterior S velocity < or = 5.2 cm/s on TTE best identified the group of patients with sludge or thrombus. CONCLUSIONS: The CLOTS multicenter pilot trial determined that TTE is useful in the detection of thrombus using harmonic imaging combined with intravenous contrast (Optison; GE Healthcare, Milwaukee, WI). Additionally, LAA wall DTI velocities on TTE are useful in determining the severity of LAA SEC and detecting sludge or thrombus.


Subject(s)
Algorithms , Atrial Fibrillation/complications , Atrial Fibrillation/diagnostic imaging , Echocardiography/methods , Image Enhancement/methods , Image Interpretation, Computer-Assisted/methods , Thrombosis/complications , Thrombosis/diagnostic imaging , Aged , Female , Humans , Male , Ohio , Pilot Projects , Reproducibility of Results , Sensitivity and Specificity
6.
Cases J ; 1(1): 431, 2008 Dec 30.
Article in English | MEDLINE | ID: mdl-19116035

ABSTRACT

BACKGROUND: We describe a case of transient left midventricular ballooning in 68-year-old male patient presented with picture of acute coronary syndrome. CASE PRESENTATION: The left ventriculogram showed mid ventricular akinesis and dilatation along with hypercontractile apex and basal segments. Follow up echocardiogram after one month showed resolution of wall motions abnormalities and normalization of the left ventricular function. CONCLUSION: This is considered as a new variant of previously reported transient left ventricular apical ballooning; the only difference in our case is the location of wall motions abnormalities.

7.
Eur Heart J ; 28(12): 1454-61, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17554145

ABSTRACT

AIMS: To determine whether the presence and severity of aortic atheroma predict long-term all-cause mortality among patients undergoing cardiac surgery. METHODS AND RESULTS: We followed 8,581 patients who underwent cardiac surgery and had routine intraoperative transoesophageal echocardiography for 2.8 years (range 0.06-6.0 years). Data regarding multiple potential confounders were prospectively collected and electronically recorded. There were 2,878 (34%) patients with no atheroma; 4,129 (48%) patients with mild atheroma; 1,215 (14%) with moderate atheroma; and 359 (4%) with severe atheroma. There were 1000 deaths. Death rates were increased in patients with moderate [relative risk (RR) 3.29, 95% CI 2.50-4.32, P < 0.0001) and severe atheroma (RR 5.21, 95% CI 3.65-7.41, P < 0.0001). After adjusting for multiple other confounders, severe atheroma remained modestly predictive of risk (adjusted RR 1.46, 95% CI 1.07-2.00, P = 0.02); but moderate atheroma and mild atheroma were not predictive of increased risk. In a propensity analysis that matched patients with comparable range of variables, severe atheroma was no longer predictive of risk (adjusted RR 1.39, 95% CI 0.87-2.23, P = 0.17). CONCLUSION: Our study shows that severe atheroma is associated with increased long-term mortality in patients undergoing cardiac surgery; however, the relationship is weak using propensity analysis, suggesting no causal association.


Subject(s)
Aortic Diseases/diagnostic imaging , Aortic Diseases/mortality , Atherosclerosis/diagnostic imaging , Atherosclerosis/mortality , Echocardiography, Transesophageal , Aged , Aged, 80 and over , Cardiac Surgical Procedures/mortality , Female , Heart Diseases/surgery , Humans , Male , Middle Aged , Prospective Studies , Risk Factors , Severity of Illness Index , Time Factors
8.
Am J Cardiol ; 96(7): 935-41, 2005 Oct 01.
Article in English | MEDLINE | ID: mdl-16188520

ABSTRACT

The ACUTE trial randomly assigned patients who had atrial fibrillation (AF) of >2 days' duration to a transesophageal echocardiographically guided or a conventional strategy before cardioversion. In the 571 patients who underwent transesophageal echocardiography (TEE) in the ACUTE trial, we assessed the relative predictive value of baseline data derived by history, transthoracic echocardiography, and TEE for prediction of thrombus and adjudicated embolism (thromboembolism) as a composite end point. TEE was performed at 70 centers in 571 patients, 549 in the transesophageal echocardiographically guided group and 22 crossovers in the conventional group. Six patients (1.1%) who had embolism and 79 (13.8%) who had thrombi were identified in this group. Thrombus was completely resolved in 76.5% of patients who had repeat transesophageal echocardiographic procedures after 31.7 +/- 7.5 days of anticoagulation. For patients who had embolic events, none had a transesophageal echocardiographically identified thrombus; 5 of 6 (83.3%) had >/=1 transesophageal echocardiographic risk factors (including spontaneous echocardiographic contrast, aortic atheroma, patent foramen ovale, atrial septal aneurysm, mitral valve strands), and 4 of 6 (66.66%) had subtherapeutic anticoagulation or no anticoagulation. Clinical, transthoracic echocardiographic, and transesophageal echocardiographic risk factors contributed significantly to the prediction of composite thrombus/embolism. However, transesophageal echocardiographic thromboembolic risk factors were the strongest predictors of thromboembolism and provided statistically significant incremental value (chi-square 38.0, p <0.001) for identification of risk. Thus, in addition to thrombus identification, TEE has significant incremental value in the identification of patients who had high thromboembolic risk. In conclusion, this study supports the role of TEE and anticoagulation monitoring in patients who have atrial fibrillation and is useful for identifying thromboembolic risk factors.


Subject(s)
Atrial Fibrillation/complications , Atrial Fibrillation/diagnostic imaging , Echocardiography, Transesophageal , Thrombosis/diagnostic imaging , Aged , Anticoagulants/administration & dosage , Atrial Fibrillation/therapy , Echocardiography , Electric Countershock , Female , Heart Atria/diagnostic imaging , Heart Diseases/diagnostic imaging , Heart Diseases/etiology , Humans , Male , Middle Aged , Randomized Controlled Trials as Topic , Thromboembolism/diagnostic imaging , Thromboembolism/etiology , Thrombosis/etiology
9.
Int J Cardiol ; 102(2): 351-3, 2005 Jul 10.
Article in English | MEDLINE | ID: mdl-15982510

ABSTRACT

A novel cardiac syndrome of left ventricular apical ballooning (Takotsubo cardiomyopathy-ampulla cardiomyopathy) involves reversible left ventricular apical ballooning (during systole) of acute onset with chest pain, electrocardiographic changes, and minimal elevation of cardiac enzymes resembling acute myocardial infarction, but without evidence of myocardial ischemia or injury. Patients have no angiographic evidence of coronary artery stenosis and there is almost always a complete recovery of left ventricular function in days to weeks. The precise etiologic basic of this syndrome is not clear but most likely it is a non-ischemic, metabolic syndrome caused by stress-induced activation of the cardiac adrenoceptors in absence of ischemia and reperfusion. Reported here is a case of stress-induced transient left ventricular apical ballooning syndrome in a young woman.


Subject(s)
Cardiomyopathies/etiology , Stress, Psychological/complications , Ventricular Dysfunction, Left/etiology , Adult , Cardiomyopathies/diagnosis , Cardiomyopathies/physiopathology , Coronary Angiography , Diagnosis, Differential , Echocardiography , Electrocardiography , Female , Follow-Up Studies , Gated Blood-Pool Imaging , Humans , Myocardial Infarction/diagnosis , Remission, Spontaneous , Stroke Volume/physiology , Syndrome , Ventricular Dysfunction, Left/diagnosis , Ventricular Dysfunction, Left/physiopathology
11.
Am J Cardiol ; 94(6): 805-7, 2004 Sep 15.
Article in English | MEDLINE | ID: mdl-15374796

ABSTRACT

The relation between C-reactive protein, an inflammatory marker, and thromboembolic risk factors was investigated in 104 patients with atrial fibrillation and found that patients with transesophageal echocardiography identified thromboembolic risk factors had greater C-reactive protein levels than those without (1.00 vs 0.302 mg/dl). C-reactive protein also correlated with clinical stroke risk factors. Increased C-reactive protein levels were also independently associated with transesophageal echocardiographic thromboembolic risk factors.


Subject(s)
Atrial Fibrillation/blood , C-Reactive Protein/metabolism , Thromboembolism/blood , Adult , Aged , Analysis of Variance , Atrial Fibrillation/complications , Biomarkers/blood , Echocardiography, Transesophageal , Female , Humans , Male , Middle Aged , ROC Curve , Risk Factors , Statistics, Nonparametric , Thromboembolism/diagnostic imaging , Thromboembolism/etiology
12.
J Am Coll Cardiol ; 43(8): 1445-52, 2004 Apr 21.
Article in English | MEDLINE | ID: mdl-15093882

ABSTRACT

OBJECTIVES: We sought to determine the association of etiology of constrictive pericarditis (CP), pericardial calcification (CA), and other clinical variables with long-term survival after pericardiectomy. BACKGROUND: Constrictive pericarditis is the result of a spectrum of primary cardiac and noncardiac conditions. Few data exist on the cause-specific survival after pericardiectomy. The impact of CA on survival is unclear. METHODS: A total of 163 patients who underwent pericardiectomy for CP over a 24-year period at a single surgical center were studied. Constrictive pericarditis was confirmed by the surgical report. Vital status was obtained from the Social Security Death Index. RESULTS: Etiology of CP was idiopathic in 75 patients (46%), prior cardiac surgery in 60 patients (37%), radiation treatment in 15 patients (9%), and miscellaneous in 13 patients (8%). Median follow-up among survivors was 6.9 years (range 0.8 to 24.5 years), during which time there were 61 deaths. Perioperative mortality was 6%. Idiopathic CP had the best prognosis (7-year Kaplan-Meier survival: 88%, 95% confidence interval [CI] 76% to 94%) followed by postsurgical (66%, 95% CI 52% to 78%) and postradiation CP (27%, 95% CI 9% to 58%). In bootstrap-validated proportional hazards analyses, predictors of poor overall survival were prior radiation, worse renal function, higher pulmonary artery systolic pressure (PAP), abnormal left ventricular (LV) systolic function, lower serum sodium level, and older age. Pericardial calcification had no impact on survival. CONCLUSIONS: Long-term survival after pericardiectomy for CP is related to underlying etiology, LV systolic function, renal function, serum sodium, and PAP. The relatively good survival with idiopathic CP emphasizes the safety of pericardiectomy in this subgroup.


Subject(s)
Cardiac Surgical Procedures/adverse effects , Pericardiectomy/methods , Pericarditis, Constrictive/etiology , Pericarditis, Constrictive/surgery , Radiotherapy/adverse effects , Virus Diseases/complications , Adult , Aged , Female , Follow-Up Studies , Humans , Male , Middle Aged , Pericarditis, Constrictive/mortality , Proportional Hazards Models , Survival Analysis , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...